Market Closed -
Other stock markets
|
Pre-market 07:49:55 am | |||
1.86 USD | +14.11% |
|
1.85 | -0.54% |
Jul. 08 | Lexicon Pharmaceuticals Names Mike Exton CEO, Jeff Wade Operating Chief | MT |
Jul. 08 | Lexicon Pharmaceuticals, Inc. Announces Appointment of Mike Exton, Ph.D. as Chief Executive Officer | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.57% | 672M | |
+20.95% | 127B | |
+23.00% | 117B | |
+26.29% | 27.77B | |
-19.75% | 20.44B | |
-14.94% | 16.62B | |
-16.56% | 15.92B | |
+11.19% | 14.74B | |
-46.65% | 14.94B | |
+57.74% | 14.38B |
- Stock Market
- Equities
- LXRX Stock
- News Lexicon Pharmaceuticals, Inc.
- Transcript : Lexicon Pharmaceuticals, Inc. Presents at 31st Annual JPMorgan Healthcare Conference, Jan-09-2013 09